![]() “We know that living with type 1 diabetes is incredibly hard work. Professor Pratik Choudhary, Clinical Lead for type 1 diabetes in the Midlands and chair of the National Diabetes Technology Network, said: Use an insulin pump and have used the freestyle libre for more than 3 months.NHS experts want to discover whether the tech can help people with diabetes, of all ages, to safely and effectively control their condition, in a real-world setting, in the first nationwide test of its kind in the world.Īmong the specific criteria for adults to take part in the pilot are those that: It can eliminate finger prick tests and prevent life-threatening hypoglycaemic and hyperglycaemia attacks, which can lead to seizures, coma or even death for people living with type 1 diabetes. The innovative ‘hybrid closed loop technology’, continually monitors blood glucose and automatically adjusts the amount of insulin given through a pump. Specialist diabetes centres taking part in the pilot in the Midlands are at University Hospitals of Derby and Burton NHS Foundation Trust, University Hospitals of Leicester NHS Trust, Nottingham University Hospitals NHS Trust and University Hospitals Birmingham NHS Foundation Trust. One century after the first diabetes patient was given insulin, around 35 NHS diabetes centres across the country are piloting the revolutionary hybrid closed loop system – also known as an ‘artificial pancreas’ – with 875 people benefiting for a year so far. Over 250 adults and children with type 1 diabetes in the Midlands have been given the opportunity to use the life-altering ‘artificial pancreas’ by the NHS as part of the first nationwide pilot to assess the effectiveness of this technology in the world. JDRF shares more here.Hundreds of people with type 1 diabetes in the Midlands benefit from life altering NHS pilot of artificial pancreases We can’t wait to hear more about this discovery. If the pilot study is successful, researchers hope to expand to a national screening program – where all children are tested for islet autoantibodies once they reach a certain age. The program was in its early stages and the researchers still needed to "do their homework" about aspects of the pilot including what age groups to target and which communities to start with, but they would also look at the potential burden on families and the cost to the health system. In addition to preventing DKA, people with autoantibodies can start monitoring early, and potentially enrol in clinical trials for new therapies that can delay or prevent the onset of T1D.ĭr Dorota Pawlak who is the chief scientific officer at peak body JDRF Australia, which is funding the research, said many families only receive a diagnosis of diabetes for their child when they are experiencing diabetic ketoacidosis, a serious complication that can sometimes be fatal. Unfortunately there is no cure for type-1 diabetes, but by identifying people earlier we can dramatically reduce the instance of diabetic ketoacidosis at diagnosis and that's a huge benefit as this could be a lifelong disease. The tests will look for particular chemical markers that can indicate if a person is at risk of developing the disease months or years before they develop symptoms. "Our aim is to be the first in the world to have routine screening for type-1 diabetes," shares Dr Kirstine Bell.ĭr Bell, a diabetes researcher based in the University of Sydney’s Charles Perkins Centre, said being able to identify the disease earlier means doctors can treat it earlier as well. Today, we are pleased to know that researchers have launched a pilot program that aims to create a non-invasive way of testing every Australian child for type-1 diabetes, led by Dr Kirstine Bell. Our participation to support this cause, came about in 2010 when Managing Director, Wendy Mead’s relative was diagnosed with diabetes. Type-1 diabetes affects over 122,300 people in Australia alone and unlike other forms of diabetes, type-1 has no known cause or cure and cannot be controlled by diet. Pinnacle People proudly supports the Juvenile Diabetes Research Foundation (JDRF) who raises money to drive world-class research into finding a cure for type 1 diabetes and its complications a lifelong autoimmune disease that usually occurs in childhood but can be diagnosed at any age. New Pilot Launch for Type-1 Diabetes Led by JDRF New Pilot Launch for Type-1 Diabetes Led by JDRF.
0 Comments
Leave a Reply. |